Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Siga Technologies call volume above normal and directionally bullish » 11:25
07/06/22
07/06
11:25
07/06/22
11:25
SIGA

Siga Technologies

$12.98 /

+0.205 (+1.60%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

SIGA Siga Technologies
$12.98 /

+0.205 (+1.60%)

Hot Stocks
Kamada secures $11.4M international Varizig procurement agreement » 06:04
07/06/22
07/06
06:04
07/06/22
06:04
KMDA

Kamada

$4.54 /

+0.05 (+1.11%)

, EBS

Emergent BioSolutions

$33.22 /

+1.35 (+4.24%)

Kamada (KMDA) has secured…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMDA Kamada
$4.54 /

+0.05 (+1.11%)

EBS Emergent BioSolutions
$33.22 /

+1.35 (+4.24%)

KMDA Kamada
$4.54 /

+0.05 (+1.11%)

EBS Emergent BioSolutions
$33.22 /

+1.35 (+4.24%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
KMDA Kamada
$4.54 /

+0.05 (+1.11%)

EBS Emergent BioSolutions
$33.22 /

+1.35 (+4.24%)

EBS Emergent BioSolutions
$33.22 /

+1.35 (+4.24%)

KMDA Kamada
$4.54 /

+0.05 (+1.11%)

EBS Emergent BioSolutions
$33.22 /

+1.35 (+4.24%)

Over a week ago
Options
Siga Technologies call volume above normal and directionally bullish » 15:05
06/29/22
06/29
15:05
06/29/22
15:05
SIGA

Siga Technologies

$11.32 /

+0.205 (+1.84%)

Bullish option flow…

Bullish option flow detected in Siga Technologies with 9,437 calls trading, 1.1x expected, and implied vol increasing over 5 points to 130.70%. Jul-22 12.5 calls and Jul-22 15 calls are the most active options, with total volume in those strikes near 6,600 contracts. The Put/Call Ratio is 0.04. Earnings are expected on August 4th.

ShowHide Related Items >><<
SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

SIGA Siga Technologies
$11.32 /

+0.205 (+1.84%)

Hot Stocks
Chimerix announces $25.3M TEMBEXA procurement agreement » 10:09
06/24/22
06/24
10:09
06/24/22
10:09
CMRX

Chimerix

$1.81 /

-0.005 (-0.28%)

, EBS

Emergent BioSolutions

$32.61 /

+0.27 (+0.83%)

Chimerix (CMRX) announced…

Chimerix (CMRX) announced Public Health Agency of Canada awarded Chimerix a contract up to $25.3M agreement to procure TEMBEXA. Execution of this contract will be the responsibility of Chimerix, as it is expected to substantially occur prior to the close of the pending transaction with Emergent BioSolutions (EBS).

ShowHide Related Items >><<
EBS Emergent BioSolutions
$32.61 /

+0.27 (+0.83%)

CMRX Chimerix
$1.81 /

-0.005 (-0.28%)

CMRX Chimerix
$1.81 /

-0.005 (-0.28%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
05/16/22 H.C. Wainwright
Chimerix price target lowered to $11 from $24 at H.C. Wainwright
12/22/21 H.C. Wainwright
Chimerix price target raised to $24 from $21 at H.C. Wainwright
11/22/21 H.C. Wainwright
Chimerix price target raised to $21 from $19 at H.C. Wainwright
EBS Emergent BioSolutions
$32.61 /

+0.27 (+0.83%)

05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
EBS Emergent BioSolutions
$32.61 /

+0.27 (+0.83%)

CMRX Chimerix
$1.81 /

-0.005 (-0.28%)

  • 15
    Sep
EBS Emergent BioSolutions
$32.61 /

+0.27 (+0.83%)

EBS Emergent BioSolutions
$32.61 /

+0.27 (+0.83%)

CMRX Chimerix
$1.81 /

-0.005 (-0.28%)

Hot Stocks
Emergent BioSolutions announces FDA acceptance of BLA for AV7909 » 06:31
06/24/22
06/24
06:31
06/24/22
06:31
EBS

Emergent BioSolutions

$32.33 /

+2.12 (+7.02%)

Emergent BioSolutions…

Emergent BioSolutions announced that the U.S. Food and Drug Administration accepted for review the Biologics License Application for AV7909. AV7909 is the company's new anthrax vaccine candidate evaluated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs. The Prescription Drug User Fee Act goal date for a decision by the FDA is in April 2023. The rolling BLA submission, completed in April 2022, is based on data from the pivotal phase 3 clinical study of AV7909 that evaluated the lot consistency, immunogenicity, and safety of the vaccine candidate following a two-dose schedule administered intramuscularly in healthy adults. It also included data from the phase 2 study that evaluated non-interference between AV7909 and antibacterial drugs approved for post-exposure prophylaxis of anthrax disease.

ShowHide Related Items >><<
EBS Emergent BioSolutions
$32.33 /

+2.12 (+7.02%)

EBS Emergent BioSolutions
$32.33 /

+2.12 (+7.02%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
EBS Emergent BioSolutions
$32.33 /

+2.12 (+7.02%)

EBS Emergent BioSolutions
$32.33 /

+2.12 (+7.02%)

EBS Emergent BioSolutions
$32.33 /

+2.12 (+7.02%)

Options
Siga Technologies call volume above normal and directionally bullish » 10:45
06/23/22
06/23
10:45
06/23/22
10:45
SIGA

Siga Technologies

$12.79 /

+0.35 (+2.81%)

Bullish option flow…

Bullish option flow detected in Siga Technologies with 10,304 calls trading, 3x expected, and implied vol increasing almost 7 points to 131.53%. Jul-22 15 calls and Aug-22 15 calls are the most active options, with total volume in those strikes near 4,600 contracts. The Put/Call Ratio is 0.11. Earnings are expected on August 4th.

ShowHide Related Items >><<
SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

SIGA Siga Technologies
$12.79 /

+0.35 (+2.81%)

Hot Stocks
Chimerix announces $9.3M TEMBEXA procurement agreement » 09:20
06/23/22
06/23
09:20
06/23/22
09:20
CMRX

Chimerix

$1.63 /

+0.025 (+1.56%)

, EBS

Emergent BioSolutions

$30.18 /

+1.025 (+3.52%)

Chimerix announced a $9.3…

Chimerix announced a $9.3 million agreement to procure TEMBEXA with a third party outside of North America, with authorization from the requisite healthcare authority. Chimerix expects to promptly provide treatment courses of TEMBEXA equivalent to the total value of the procurement contract. Execution of this contract will be the responsibility of Chimerix, as it is expected to occur prior to the close of the pending transaction with Emergent BioSolutions.

ShowHide Related Items >><<
EBS Emergent BioSolutions
$30.18 /

+1.025 (+3.52%)

CMRX Chimerix
$1.63 /

+0.025 (+1.56%)

CMRX Chimerix
$1.63 /

+0.025 (+1.56%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
05/16/22 H.C. Wainwright
Chimerix price target lowered to $11 from $24 at H.C. Wainwright
12/22/21 H.C. Wainwright
Chimerix price target raised to $24 from $21 at H.C. Wainwright
11/22/21 H.C. Wainwright
Chimerix price target raised to $21 from $19 at H.C. Wainwright
EBS Emergent BioSolutions
$30.18 /

+1.025 (+3.52%)

05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
EBS Emergent BioSolutions
$30.18 /

+1.025 (+3.52%)

CMRX Chimerix
$1.63 /

+0.025 (+1.56%)

  • 15
    Sep
EBS Emergent BioSolutions
$30.18 /

+1.025 (+3.52%)

EBS Emergent BioSolutions
$30.18 /

+1.025 (+3.52%)

CMRX Chimerix
$1.63 /

+0.025 (+1.56%)

Hot Stocks
Siga Technologies announces $13M of procurement orders for oral TPOXX » 08:07
06/23/22
06/23
08:07
06/23/22
08:07
SIGA

Siga Technologies

$12.43 /

+0.57 (+4.81%)

SIGA Technologies…

SIGA Technologies announced approximately $13M of procurement orders for oral TPOXX, including $11M for initial procurement from two new international jurisdictions and an approximate $2M order from a country in the Asia Pacific region that has an established contract for oral TPOXX. "Procurement orders from new international jurisdictions have occurred as SIGA has received a large and ongoing number of inquiries about accessing oral TPOXX, highlighting the importance of health security preparedness," said Phil Gomez, CEO of SIGA. "We expect a portion of the courses of oral TPOXX delivered under these orders will be used for the treatment of active monkeypox cases and represent a first step in the response to this outbreak by the global public health community. By increasing both the scale and scope of TPOXX stockpiling, countries can be better prepared for the outbreak risks of smallpox, monkeypox, and other viruses in the orthopoxvirus family of viruses and make sure that patients are able to access a proven safe and effective treatment." The orders from the new international jurisdictions represent the first procurements of oral TPOXX directly in response to the evolving global monkeypox outbreak. One of the new jurisdictions is located in Europe and the other is located in the Asia Pacific region. SIGA currently expects to deliver approximately $4M of oral TPOXX under the two new contracts within the next 45 days. The remaining approximately $7M of oral TPOXX is expected to be delivered in 2023. With respect to the order from an existing customer, SIGA recently fulfilled the order by delivering $2M of oral TPOXX. In combination with a delivery of a previously disclosed order of $2.8 million, SIGA has delivered in total approximately $5M of oral TPOXX to this country during this quarter. Meridian Medical Technologies is the counterparty to the international contracts and SIGA will be responsible for the manufacture and delivery of product.

ShowHide Related Items >><<
SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

SIGA Siga Technologies
$12.43 /

+0.57 (+4.81%)

Hot Stocks
Emergent BioSolutions: CHIKV VLP Phase 2 data published in The Lancet » 06:34
06/21/22
06/21
06:34
06/21/22
06:34
EBS

Emergent BioSolutions

$28.59 /

+1.19 (+4.34%)

Emergent BioSolutions…

Emergent BioSolutions announced that two-year persistence data from its phase 2 clinical study evaluating the safety and immunogenicity of the company's investigational chikungunya virus virus-like particle vaccine candidate were published in The Lancet Infectious Diseases. The article, Safety and immunogenicity of PXVX0317, an aluminum hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial, is available online. Emergent's CHIKV VLP vaccine candidate was well tolerated and induced a robust and durable serum neutralizing antibody immune response against the Chikungunya virus up to two years. A single dose, 40 undefined injection of adjuvanted CHIKV VLP is being further investigated in phase 3 clinical trials.

ShowHide Related Items >><<
EBS Emergent BioSolutions
$28.59 /

+1.19 (+4.34%)

EBS Emergent BioSolutions
$28.59 /

+1.19 (+4.34%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
05/04/22 Wells Fargo
Emergent BioSolutions price target lowered to $38 from $46 at Wells Fargo
04/29/22 Cantor Fitzgerald
Emergent BioSolutions downgraded to Neutral from Overweight at Cantor Fitzgerald
04/29/22 Cowen
Emergent BioSolutions price target lowered to $30 from $40 at Cowen
EBS Emergent BioSolutions
$28.59 /

+1.19 (+4.34%)

EBS Emergent BioSolutions
$28.59 /

+1.19 (+4.34%)

EBS Emergent BioSolutions
$28.59 /

+1.19 (+4.34%)

Options
Siga Technologies call volume above normal and directionally bullish » 10:45
06/07/22
06/07
10:45
06/07/22
10:45
SIGA

Siga Technologies

$11.54 /

+0.92 (+8.66%)

Bullish option flow…

Bullish option flow detected in Siga Technologies with 7,671 calls trading, 2x expected, and implied vol increasing over 2 points to 164.67%. Jun-22 17.05 calls and Jun-22 15 calls are the most active options, with total volume in those strikes near 3,300 contracts. The Put/Call Ratio is 0.04. Earnings are expected on August 4th.

ShowHide Related Items >><<
SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

05/20/22 Benchmark
Benchmark says Emergent, Siga, Chimerix strength attributable to monkeypox scare
SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

SIGA Siga Technologies
$11.54 /

+0.92 (+8.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.